Gion M - Search Results

1

Development of a website and biobank database for the Nanosized Cancer Polymarker Biochip Project: a Multicenter Italian Experience.

Leon AE, Fabricio AS, Benvegnù F, Michilin S, Secco A, Spangaro O, Meo S, Gion M. Leon AE, et al. Among authors: gion m. Int J Biol Markers. 2011 Jul-Sep;26(3):197-206. doi: 10.5301/JBM.2011.8623. Epub 2011 Sep 7. Int J Biol Markers. 2011. PMID: 21928249 Free article.

2

Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.

Gion M, Mione R, Gatti C, Dittadi R, Leon A, Castiglioni C, Nascimben O, Bruscagnin G. Gion M, et al. Breast Cancer Res Treat. 1990 Nov;17(1):15-21. doi: 10.1007/BF01812680. Breast Cancer Res Treat. 1990. PMID: 1965704

3

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.

Gion M, Mione R, Nascimben O, Valsecchi M, Gatti C, Leon A, Bruscagnin G. Gion M, et al. Br J Cancer. 1991 May;63(5):809-13. doi: 10.1038/bjc.1991.179. Br J Cancer. 1991. PMID: 2039707 Free PMC article.

4

Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.

Gion M, Mione R, Gatti C, Dittadi R, Leon A, Nascimben O, Pizzorno B, Bruscagnin G. Gion M, et al. Tumori. 1990 Aug 31;76(4):360-4. doi: 10.1177/030089169007600411. Tumori. 1990. PMID: 2399565

5

Biochemical parameters in the cytosol of breast cancer.

Dittadi R, Mione R, Gion M, Leon A, Bruscagnin G. Dittadi R, et al. Among authors: gion m. Int J Biol Markers. 1988 Jan-Mar;3(1):70. doi: 10.1177/172460088800300119. Int J Biol Markers. 1988. PMID: 3249050 No abstract available.

6

Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancer.

Gion M, Cappelli G, Mione R, Pistorello M, Meo S, Vignati G, Fortunato A, Saracchini S, Biasioli R, Giulisano M. Gion M, et al. Int J Biol Markers. 1994 Jul-Sep;9(3):135-9. doi: 10.1177/172460089400900302. Int J Biol Markers. 1994. PMID: 7829892 Clinical Trial.

7

Biochemical parameters for prognostic evaluation in patients with breast cancer.

Gion M, Mione R, Pappagallo GL, Gatti C, Nascimben O, Sampognaro E, Meo S. Gion M, et al. Anticancer Res. 1994 Mar-Apr;14(2B):693-8. Anticancer Res. 1994. PMID: 8010728

8

Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.

Gion M, Plebani M, Mione R, Penzo C, Meo S, Burlina A. Gion M, et al. Br J Cancer. 1994 Apr;69(4):721-5. doi: 10.1038/bjc.1994.136. Br J Cancer. 1994. PMID: 8142260 Free PMC article.

9

PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.

Gion M, Mione R, Pappagallo GL, Gatti C, Nascimben O, Bari M, Leon AE, Vinante O, Bruscagnin G. Gion M, et al. Br J Cancer. 1993 Aug;68(2):374-9. doi: 10.1038/bjc.1993.343. Br J Cancer. 1993. PMID: 8347494 Free PMC article.

10

Third-generation PSA: ultrasensitive or ultraprecise assay?

Mione R, Barichello M, Sartorello P, Leon A, Barioli P, Gion M. Mione R, et al. Among authors: gion m. Int J Biol Markers. 1995 Oct-Dec;10(4):229-33. doi: 10.1177/172460089501000408. Int J Biol Markers. 1995. PMID: 8750651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page